Role of DAZgene microdeletionandAMH changesin Azoospermia and Oligozoospermia patients
DOI:
https://doi.org/10.61841/dj4afd73Keywords:
DAZ, anti-mullerian hormone, microdeletionAbstract
This study aimed to detect the microdeletions ofDAZin azoospermic and oligozoospermic patients and assessment of anti-müllerian hormone (AMH). One hundred patients included in this study,amplification of PCR by specific primer sets. All the samples tested for the presence of STS markers sY254 to detect AZFcDAZ gene deletions.The processed DNA was subjected to monoplex PCR, each specific region of the AZF locusamplifies by primer pair. AMH hormone level measured by ELISA kit.microdeletion of DAZ found in 20 of samples, present in 10(50%) in azoospermic patients with decreased in AMH level and oligozoospermic patients had 7(35%) while 3(15%) in normozoospermic men.Based on results, this study has shown DAZ genes microdeletion and decrease in AMH level are a major causes of male infertilityin this study and this microdeletions were more incidences in azoospermia more than oligozoospermia.
Downloads
References
1. Ambulkar, P. S. and Pande, S. S. (2017). Male infertility: Screening of Azoospermia Factor (AZF) Microdeletionn In Idiopathic Infertile Male, Journal of Experimental Biology and Agricultural Sciences, Vol. 5(1).
2. Nailwal, M. and Chauhan, J. (2016). Screening of y-chromosome microdeletion in the azfc sub-region of infertile men, Gujarat, India, IJBPAS, 5(11): 2828–2839.
3. Xiao-Wei Yu.; Wei, Z.T.; Jiang, Y.T. and Zhang, S.L. (2015). Y chromosome azoospermia factor region microdeletions and transmission characteristics in azoospermic and severe oligozoospermic patients. Int J Clin and Exp Med, 8: 14634–14646.
4. Haroon Latif Khan, Shahzad Bhatti, Samina Suhail, Rohina Gul, Aisha Awais, Humaira Hamayun, Farah Enver, Sana Abbas, Zahira Hassan, Rameen Nisar, Saba Sardar and Warda Asif. (2019). Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years. Reproductive Biology and Endocrinology, 17:20.
5. Gustavo A., Rosa M., Edmund C. B., Marcos F. S. de Sá. (2018). About the Anti-Müllerian Hormone (AMH) Uses in the Clinical Practice, Rev Bras Ginecol Obstet, 40: 661–663.
6. Naafs, M. (2017). Measurement of the Anti-Müllerian hormone (AMH) in endocrinology: A mini-review. Invest Gynecol Res Women’s Health, 1(2).
7. Tehrani, F.; Mansournia, A.; Solaymani-Dodaran, M.; Minooee, S. and Azizi, F. (2017). Serum variations of anti-mullerian hormone and total testosterone with aging in healthy adult Iranian men: A population-based study. PLoS ONE, 12(7): e0179634.
8. Ewa, M.; Adam, H.; Marta, K. and Wojciech, D. (2013). Serum AMH in Physiology and Pathology of Male Gonads. International Journal of Endocrinology, 2013: 6.
9. Yen-Ni, T.; Ying-Hung, L.; Yung-Chieh, T.; Chao-Chin, H.; Pao-Lin, K.; and Yung-Ming, L. (2007). A simplified gene-specific screen for Y chromosome deletions in infertile men. Fertility and Sterility, 87: 1291–1300.
10. Dohle, G.R.; Halley, D.J.; Van Hemel, J.O.; van den O.; Pieters, M.H.; Weber, R.F. and Govaerts, L.C.P. (2002). Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Human Reproduction, 17: 13–16.
11. Malekasgar, A.M. and Mombaini, H. (2008). Screening of “Y” chromosome microdeletions in Iranian infertile males. J Hum Reprod Sci., 1(1): 2–9.
12. Dhanoa, J.K.; Mukhopadhyay, C.S. and Arora, J.S. (2016). Y-chromosomal genes affecting male fertility: A review. Veterinary World, 9(7): 783–791.
13. Vaszko, T.; Papp, J.; Krausz, C.; Casamonti, E.; Géczi, L. and Olah, E. (2016). Discrimination of Deletion and Duplication Subtypes of the Deleted in Azoospermia Gene Family in the Context of Frequent Interloci Gene Conversion. PLoS ONE, 11(10): e0163936.
14. El-Nahass, Y.H.; Amr, E.; Ahmed, S.Z.; Mekky, R.Y.; Mohamed, S.F.; Esraa, M. and Mohasseband, F.A. (2017). Y-Chromosome Microdeletions and their association with male factor infertility in Egyptian patients. Life Science Journal, 14(6).
15. Nailwal, M. and Chauhan, J. (2016). SCREENING OF Y-CHROMOSOME MICRODELETION IN THE AZFC SUB-REGION OF INFERTILE MEN, GUJARAT, INDIA. IJBPAS, 5(11): 2828–2839.
16. Liu, X.G.; Hu, H.Y.; Guo, Y.H. and Sun, Y.P. (2016). Correlation between Y chromosome microdeletion and male infertility. Genetics and Molecular Research, 15(2).
17. Chiang, H.S.; Wei, H.J. and Chen, Y.T. (2000). Genetic screening for patients with azoospermia and severe oligo-asthenospermia. Int. J. Androl., 23: 20–25.
18. Dohle, G.R.; Colpi, G.M.; Hargreave, T.B.; Papp, G.K.; Jungwirth, A. and Weidner, W. (2005). Guidelines on male infertility. Eur Urol, 48: 703–711.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
